Researchers from Boston University School of Medicine (BUSM) have shown that using magnetic resonance imaging (MRI) to measure blood flow over atherosclerotic plaques could help identify plaques at risk for thrombosis. The findings, which appear in the March issue of Circulation Cardiovascular Imaging, offer a non-invasive application in the diagnosis and treatment of patients with atherosclerosis.

Hospital Sisters Health System (HSHS), which sponsors 13 hospitals in 12 communities across Illinois and Wisconsin, is migrating to an integrated information system and enterprise solution for the sites. Epiphany's cardio server was chosen as the enterprise-wide electrocardiogram (ECG) management system for HSHS.

An estimated 5,000 nuclear medicine and molecular imaging professionals are expected to gather in June for the 2013 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) to discuss the latest advances in radiotracers, imaging modalities, radionuclide therapies and quality.

InTouch Health has announced the launch of the ControlStation (CS) App for iPad, making it easier for doctors to provide real-time, acute telemedicine consults with patients. From a single interface, doctors can now connect from iPads and iPad Minis to provide patient care through any of the Company’s Food and Drug Administration (FDA)-cleared, purpose-built remote presence devices. An interface designed specifically for acute care telemedicine, it integrates clinical patient data and medical radiology imaging tools through a single user login.

Olympus received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Articulating HD 3-D Laparoscopic Surgical Video System. It delivers value to surgeons and patients by reducing surgical errors and improving the speed, accuracy and precision of surgical tasks such as dissection, grasping and suturing when compared with traditional 2-D surgical systems, based on internal Olympus testing conducted using a simulated surgical model. This is accomplished by restoring natural 3-D vision and depth perception when performing laparoscopic procedures and is independent of a surgeon’s skill level.


 Medtronic Inc. announced market release of the CardioGuide Implant System, a novel real-time navigation system for cardiac resynchronization therapy pacemakers and defibrillators (CRT-P and CRT-D), in the United States and Canada. The system helps physicians determine the most appropriate location for left-ventricular lead placement by generating 3-D images of the cardiac veins; enhanced software for the system will be commercially available later this year that also analyzes the motion of select cardiac vessels on the left side of the heart. Clinical studies have shown that appropriate left-ventricular lead placement may improve CRT response in heart failure patients.

CardioFocus Inc. announced that as of late 2012, more than 1,000 clinical cases have been performed worldwide using the HeartLight technology. The company hosted an expert symposium to review the clinical application of HeartLight and key observations made during the first 1,000 cases in January.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now